Herbs (Global Traditional) · Native American
Spikenard (Aralia racemosa) (Aralia racemosa)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Spikenard (Aralia racemosa) is a Native American medicinal plant containing triterpene saponins that may provide respiratory support. The saponin compounds appear to work through anti-inflammatory mechanisms targeting bronchial tissues.
Aralia racemosa, commonly known as American spikenard, is a rhizomatous herbaceous perennial plant in the Ginseng family (Araliaceae) native to moist, rich woods in eastern North America from Quebec to Georgia. The medicinal part consists of dried rhizomes and roots, traditionally prepared as infusions or tinctures, containing flavonoids, phenols, saponins, terpenoids, and glycosides.
No human clinical trials, RCTs, or meta-analyses specific to Aralia racemosa have been conducted according to available research. Modern scientific investigation is extremely limited, with research confined to basic phytochemical analysis identifying flavonoids, phenols, saponins, terpenoids, and glycosides in the plant material.
Traditional eclectic medicine recommendations include: Specific tincture - 5 to 30 drops in water, 4 times daily; Infusion - 1/2 to 2 fluid ounces. No clinically studied dosages exist due to absence of modern trials. Consult a healthcare provider before starting any new supplement.
Spikenard (Aralia racemosa) is not consumed as a food source and therefore lacks a conventional nutritional profile in terms of macronutrients (protein, fat, carbohydrates) or caloric value. Its relevance is phytochemical rather than nutritional. Key bioactive compounds include: • **Triterpenoid saponins** (araliosides/aralosides) — estimated 2–5% of dried root weight; these are the primary pharmacologically active constituents responsible for expectorant and anti-inflammatory activity; bioavailability is generally low orally due to poor intestinal absorption, though gut microbiota may hydrolyze glycosides to more bioavailable aglycones. • **Diterpenoid acids** (including ent-kaurene-type diterpenes such as continentalic acid and related compounds) — trace to low concentrations (~0.1–0.5% of dried root); may contribute to antimicrobial and anti-inflammatory effects. • **Essential oils** (volatile fraction) — approximately 0.2–0.8% of dried root; containing sesquiterpenes and monoterpenes; these contribute to the aromatic quality and may have mild antimicrobial properties. • **Polyacetylenes** (falcarinol-type compounds) — present in trace amounts as is common in the Araliaceae family; known to exhibit cytotoxic and anti-inflammatory properties in related species. • **Phenolic compounds and tannins** — estimated 1–3% of dried root; including caffeic acid derivatives and flavonoid glycosides; these contribute antioxidant capacity (ORAC values not established for this species specifically). • **Minerals**: Root material likely contains potassium, calcium, magnesium, and iron in small amounts typical of wild herbaceous root tissue, but no quantitative analyses specific to A. racemosa are published. • **Fiber**: Dried root contains insoluble fiber (cellulose, lignin) but this is incidental to its use as a medicine, not a dietary consideration. • **Vitamins**: No significant vitamin content has been documented. Note: Virtually all phytochemical data is extrapolated from closely related Aralia species (A. nudicaulis, A. cordata, A. elata) or from limited analytical work on A. racemosa itself. No standardized extract specifications or comprehensive metabolomic profiling currently exist for this species. The root and rhizome are the primary parts used traditionally, typically prepared as decoctions or tinctures, which affects the extraction efficiency and bioavailability of active compounds.
Spikenard's triterpene saponins, including oleanolic acid derivatives, appear to modulate inflammatory pathways in respiratory tissues. These compounds may inhibit pro-inflammatory cytokines and reduce mucus membrane irritation. The saponins also demonstrate potential expectorant properties by affecting bronchial secretions.
Currently, no modern clinical trials have evaluated spikenard's therapeutic effects in humans. Traditional use evidence comes primarily from Native American practices and 19th-century eclectic medicine documentation. Laboratory studies on saponin compounds suggest anti-inflammatory activity, but specific research on Aralia racemosa extracts remains limited. The respiratory benefits are based solely on historical use patterns rather than controlled human studies.
Spikenard is generally considered safe when used traditionally, but comprehensive safety data is lacking. Potential side effects may include gastrointestinal upset due to saponin content. No specific drug interactions have been documented, though caution is advised with respiratory medications. Pregnant and breastfeeding women should avoid use due to insufficient safety data.
